The latest news, tips and updates
from The Partnership at Drugfree.org.
Facing two felony drug charges for possession of marijuana and prescription medication, the son of former Vice President Al Gore has pled guilty and will enter a Malibu, Calif., addiction treatment program rather than prison. …
A federal judge heard emotional testimony from OxyContin overdose victims' families during the sentencing hearing for three pharmaceutical executives accused of misleading the public about the drugs, but in the end the officials got off with fines but no jail time. …
Former New York mayor and presidential candidate Rudolph Giuliani is being criticized for image consulting that helped pharmaceutical firm Purdue Pharma as the company grappled with criticism over the marketing of the painkiller OxyContin. …
The National Institute on Drug Abuse is investigating whether Suboxone -- a mix of buprenorphine and naloxone -- is effective in treating patients addicted to prescription opiate-based painkillers. …
The U.S. Centers for Disease Control and Prevention says that antidepressants are now the most commonly prescribed drugs in the U.S., totaling 118 million prescriptions in 2005. …
The arrest of Al Gore III on charges of illegal possession of marijuana, Adderall, Xanax, Valium and Vicodin is helping to raise awareness about the problem of prescription drug abuse. …
A plea-bargain arrangement that allows Purdue Pharma executives to avoid jail in exchange for guilty pleas for illegally marketing Oxycontin is being questioned by a federal judge. …
Brookhaven National Laboratory researchers say that children who start taking prescription medications for attention-deficit hyperactivity disorder (ADHD) may be at higher risk for alcohol and other drug abuse later in life. …
For three years in a row the number of rogue websites selling controlled prescription drugs has increased, according to a new White Paper released by The National Center on Addiction and Substance Abuse (CASA) at Columbia University. …
Purdue Pharma, the pharmaceutical firm that makes the opiate painkiller OxyContin, has agreed to pay $634 million in fines for falsely claiming that the drug was less addictive and has less potential for abuse than other similar drugs. The fines were levied against both the company and three of its top executives. …
Get the latest news, insights, resources and developments.
